MElanoma Research Lymph Node Prediction Implementation National_001

Active, not recruitingOBSERVATIONAL
Enrollment

1,820

Participants

Timeline

Start Date

August 25, 2021

Primary Completion Date

June 28, 2024

Study Completion Date

June 30, 2029

Conditions
Melanoma
Trial Locations (9)

10065

Memorial Sloan Kettering Cancer Center, New York

27705

Duke University, Durham

30322

Emory University School of Medicine, Atlanta

33612

Moffitt Cancer Center, Tampa

40292

University of Louisville, Louisville

40506

University of Kentucky, Lexington

48109

University of Michigan, Ann Arbor

55905

Mayo Clinic, Rochester

84112

Huntsman Cancer Institute, Salt Lake City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

SkylineDx

INDUSTRY

NCT04759781 - MElanoma Research Lymph Node Prediction Implementation National_001 | Biotech Hunter | Biotech Hunter